Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Targeting steroid resistance in T-cell acute lymphoblastic leukemia.

De Smedt R, Morscio J, Goossens S, Van Vlierberghe P.

Blood Rev. 2019 Nov;38:100591. doi: 10.1016/j.blre.2019.100591. Epub 2019 Jul 19. Review.

PMID:
31353059
2.

Correction to: Secondary B-cell lymphoma associated with the Epstein-Barr virus in chronic lymphocytic leukemia patients.

Morscio J, Bittoun E, Volders N, Lurquin E, Wlodarska I, Gheysens O, Vandenberghe P, Verhoef G, Demaerel P, Dierickx D, Sagaert X, Janssens A, Tousseyn T.

J Hematop. 2018 May 4;11(2):65. doi: 10.1007/s12308-018-0323-5. eCollection 2018 Jun.

3.

Pre-clinical evaluation of second generation PIM inhibitors for the treatment of T-cell acute lymphoblastic leukemia and lymphoma.

De Smedt R, Peirs S, Morscio J, Matthijssens F, Roels J, Reunes L, Lintermans B, Goossens S, Lammens T, Van Roy N, Touzart A, Jenni S, Tsai YC, Lovisa F, Mussolin L, Serafin V, Van Nieuwerburgh F, Deforce D, Uyttebroeck A, Tousseyn T, Burkhardt B, Klapper W, De Moerloose B, Benoit Y, Macintyre E, Bourquin JP, Basso G, Accordi B, Bornhauser B, Meijerink J, Vandenberghe P, Van Vlierberghe P.

Haematologica. 2019 Jan;104(1):e17-e20. doi: 10.3324/haematol.2018.199257. Epub 2018 Aug 3. No abstract available.

4.

Richter transformation driven by Epstein-Barr virus reactivation during therapy-related immunosuppression in chronic lymphocytic leukaemia.

García-Barchino MJ, Sarasquete ME, Panizo C, Morscio J, Martinez A, Alcoceba M, Fresquet V, Gonzalez-Farre B, Paiva B, Young KH, Robles EF, Roa S, Celay J, Larrayoz M, Rossi D, Gaidano G, Montes-Moreno S, Piris MA, Balanzategui A, Jimenez C, Rodriguez I, Calasanz MJ, Larrayoz MJ, Segura V, Garcia-Muñoz R, Rabasa MP, Yi S, Li J, Zhang M, Xu-Monette ZY, Puig-Moron N, Orfao A, Böttcher S, Hernandez-Rivas JM, Miguel JS, Prosper F, Tousseyn T, Sagaert X, Gonzalez M, Martinez-Climent JA.

J Pathol. 2018 May;245(1):61-73. doi: 10.1002/path.5060. Epub 2018 Mar 30.

PMID:
29464716
5.

Identification of distinct subgroups of EBV-positive post-transplant diffuse large B-cell lymphoma.

Morscio J, Finalet Ferreiro J, Vander Borght S, Bittoun E, Gheysens O, Dierickx D, Verhoef G, Wlodarska I, Tousseyn T.

Mod Pathol. 2017 Mar;30(3):370-381. doi: 10.1038/modpathol.2016.199. Epub 2017 Jan 6.

6.

Genetic landscape of T- and NK-cell post-transplant lymphoproliferative disorders.

Margolskee E, Jobanputra V, Jain P, Chen J, Ganapathi K, Nahum O, Levy B, Morscio J, Murty V, Tousseyn T, Alobeid B, Mansukhani M, Bhagat G.

Oncotarget. 2016 Jun 21;7(25):37636-37648. doi: 10.18632/oncotarget.9400.

7.

Recent insights in the pathogenesis of post-transplantation lymphoproliferative disorders.

Morscio J, Tousseyn T.

World J Transplant. 2016 Sep 24;6(3):505-16. doi: 10.5500/wjt.v6.i3.505. Review.

8.

Secondary B-cell lymphoma associated with the Epstein-Barr virus in chronic lymphocytic leukemia patients.

Morscio J, Bittoun E, Volders N, Lurquin E, Wlodarska I, Gheysens O, Vandenberghe P, Verhoef G, Demaerel P, Dierickx D, Sagaert X, Janssens A, Tousseyn T.

J Hematop. 2016 May 21;9:113-120. doi: 10.1007/s12308-016-0273-8. eCollection 2016. Erratum in: J Hematop. 2018 May 4;11(2):65.

9.

Detection of bone marrow involvement in newly diagnosed post-transplant lymphoproliferative disorder: (18)F-fluorodeoxyglucose positron emission tomography/computed tomography versus bone marrow biopsy.

Gheysens O, Thielemans S, Morscio J, Boeckx N, Goffin KE, Deroose CM, Sagaert X, Wlodarska I, Verhoef G, Dierickx D, Tousseyn T.

Leuk Lymphoma. 2016 Oct;57(10):2382-8. doi: 10.3109/10428194.2016.1140162. Epub 2016 Feb 8.

PMID:
26854937
10.

EBV-Positive and EBV-Negative Posttransplant Diffuse Large B Cell Lymphomas Have Distinct Genomic and Transcriptomic Features.

Ferreiro JF, Morscio J, Dierickx D, Vandenberghe P, Gheysens O, Verhoef G, Zamani M, Tousseyn T, Wlodarska I.

Am J Transplant. 2016 Feb;16(2):414-25. doi: 10.1111/ajt.13558. Epub 2016 Jan 18.

11.

Post-transplant molecularly defined Burkitt lymphomas are frequently MYC-negative and characterized by the 11q-gain/loss pattern.

Ferreiro JF, Morscio J, Dierickx D, Marcelis L, Verhoef G, Vandenberghe P, Tousseyn T, Wlodarska I.

Haematologica. 2015 Jul;100(7):e275-9. doi: 10.3324/haematol.2015.124305. Epub 2015 Mar 20. No abstract available.

12.

Clinicopathologic comparison of plasmablastic lymphoma in HIV-positive, immunocompetent, and posttransplant patients: single-center series of 25 cases and meta-analysis of 277 reported cases.

Morscio J, Dierickx D, Nijs J, Verhoef G, Bittoun E, Vanoeteren X, Wlodarska I, Sagaert X, Tousseyn T.

Am J Surg Pathol. 2014 Jul;38(7):875-86. doi: 10.1097/PAS.0000000000000234.

PMID:
24832164
13.

Validation of prognostic scores in post-transplantation lymphoproliferative disorders.

Dierickx D, Tousseyn T, Morscio J, Fieuws S, Verhoef G.

J Clin Oncol. 2013 Sep 20;31(27):3443-4. doi: 10.1200/JCO.2013.50.3326. Epub 2013 Aug 19. No abstract available.

PMID:
23960181
14.

Molecular pathogenesis of B-cell posttransplant lymphoproliferative disorder: what do we know so far?

Morscio J, Dierickx D, Tousseyn T.

Clin Dev Immunol. 2013;2013:150835. doi: 10.1155/2013/150835. Epub 2013 Apr 14. Review.

15.

Gene expression profiling reveals clear differences between EBV-positive and EBV-negative posttransplant lymphoproliferative disorders.

Morscio J, Dierickx D, Ferreiro JF, Herreman A, Van Loo P, Bittoun E, Verhoef G, Matthys P, Cools J, Wlodarska I, De Wolf-Peeters C, Sagaert X, Tousseyn T.

Am J Transplant. 2013 May;13(5):1305-16. doi: 10.1111/ajt.12196. Epub 2013 Mar 14.

16.

Single-center analysis of biopsy-confirmed posttransplant lymphoproliferative disorder: incidence, clinicopathological characteristics and prognostic factors.

Dierickx D, Tousseyn T, Sagaert X, Fieuws S, Wlodarska I, Morscio J, Brepoels L, Kuypers D, Vanhaecke J, Nevens F, Verleden G, Van Damme-Lombaerts R, Renard M, Pirenne J, De Wolf-Peeters C, Verhoef G.

Leuk Lymphoma. 2013 Nov;54(11):2433-40. doi: 10.3109/10428194.2013.780655. Epub 2013 Apr 9.

PMID:
23442063
17.

Clinicopathological characteristics of posttransplant lymphoproliferative disorders of T-cell origin: single-center series of nine cases and meta-analysis of 147 reported cases.

Herreman A, Dierickx D, Morscio J, Camps J, Bittoun E, Verhoef G, De Wolf-Peeters C, Sagaert X, Tousseyn T.

Leuk Lymphoma. 2013 Oct;54(10):2190-9. doi: 10.3109/10428194.2013.775436. Epub 2013 Mar 27.

PMID:
23402267
18.

The accuracy of positron emission tomography in the detection of posttransplant lymphoproliferative disorder.

Dierickx D, Tousseyn T, Requilé A, Verscuren R, Sagaert X, Morscio J, Wlodarska I, Herreman A, Kuypers D, Van Cleemput J, Nevens F, Dupont L, Uyttebroeck A, Pirenne J, De Wolf-Peeters C, Verhoef G, Brepoels L, Gheysens O.

Haematologica. 2013 May;98(5):771-5. doi: 10.3324/haematol.2012.074500. Epub 2012 Oct 12.

Supplemental Content

Loading ...
Support Center